Call for Late Breaking Abstracts
Late Breaking Abstracts (Posters only): Opened
Deadline for Late Breaking Abstracts: September 18, 2017
Notification of Accepted Abstracts: September 25, 2017
Abstracts for poster only are invited for consideration for the Tissue Engineering & Regenerative Medicine International Society - Americas (TERMIS-AM) 2017 Conference and Exposition, December 3 – 6, 2017 at the Charlotte Convention Center in Charlotte, NC.
The TERMIS-AM 2017 Conference will feature an outstanding scientific program bringing together national and international communities of scientists, clinicians, industry leaders, post-doctoral fellows, graduate students entrepreneurs, and representatives of government funding agencies engaged in the fields of tissue engineering and regenerative medicine.
Individuals from academia, industry and government are invited to present timely research findings in all areas of tissue engineering/regenerative medicine.
Abstracts submitters should choose one of the following categories:
Review Criteria and Selection of Abstracts
The most innovative and promising basic, applied and clinical research within the following topical areas will be considered for poster presentations. Abstracts based on new research that has not been presented or published elsewhere will be given primary consideration.
Abstracts will be reviewed by members of the Program Planning Committee based on the following criteria:
- Quality of scientific content
- Originality of research
- Contribution and relevance to the field of tissue engineering/regenerative medicine
- Adherence to required format
- Late breaking abstracts are only considered for poster presentation.
- Abstracts that are not supported by full technical disclosure or are promotional rather than scientific in nature are discouraged.
- Abstracts will be submitted for inclusion in conference proceedings (online materials).
- Common reasons for abstract rejection are:
- Poorly supported research hypothesis/objective/rationale
- Experimental plan vague and/or not well documented/described
- Insufficient data collected
- Poor analysis of the data
- Conclusions not supported by the results
- Poor grammar/figures/tables
The abstract should clearly describe the nature of the research and the problem it addresses, and be presented in such language as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize the objectives of the research, the methodology employed, results, and their significance.
Content should be organized as follows:
- Introduction, including hypothesis and objectives
- Materials and Methods
- Results, in appropriate detail
- Discussion and Conclusions
- References, to key literature
Authors must submit their abstract electronically by clicking on the link below:
Abstract Submission Site
The ONLY option for selection is Late Breaking Poster abstract submission.
- The abstract length is limited to 250 words. Which includes the overview as well as any references and authors.
- Please no figures or tables in the abstract.
- All abstracts will be published in the "Tissue Engineering, Part A" journal, if do not wish to have your abstract published please indicate so during your submission. All authors will have to agree to the submission and the publication of the abstract.
Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font and mixed case font followed by a single return. Do not put a period at the end of the title.
Example for Title: This is a Properly Formatted Abstract Title
Author(s): In upper and lower case letters as follows: First Name, Middle Initial Last Name of each author (underline the name of the presenting author) with the corresponding institution of the author's. Follow with a single return.
** All abstract presenters are expected to pay their own travel expenses and conference registration fee(s).
Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting the abstract file.
References: May be included at the end. Please use a standard format, such as that shown below:
1. Langer R, Vacanti JP. Tissue Engineering. Science 260, 920, 1993.
Acknowledgments: Support from outside sources, such as Research Grants, should be listed here. Based on the standards set by the Accreditation Council for Continuing Medical Education and guidelines of the Food and Drug Administration as endorsed by the American Medical Association, any conflict of interest must be clearly recognizable. The indication of outside support does not affect the decision of abstract acceptance or rejection.
Disclosures: Include any disclosure information here. In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the subject. Examples include, but are not limited to:
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers bureau
Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.
You may revise your abstract no later than 11:59 pm Eastern Standard Time on September 18, 2017, by returning to the site and logging in again. After the deadline, all completed abstracts in the system will be sent to the program committee for review. Any abstracts left "incomplete" will not be sent for review. There are no exceptions.
If the abstract must be withdrawn, the TERMIS AM office must be notified in writing at least ONE month prior to the meeting via e-mail to Melanie Ryan, email@example.com
All presenters are expected to cover their own travel and lodging expenses and pay the conference registration fees. Date of presentation cannot be guaranteed.
For More Information
For more information on abstract content, format and submission procedure, contact:
TERMIS-AM Meeting Manager